Comparison of the effect of daily 1mg minodronate with 5 mg alendronate in Japanese women with postmenopausal osteoporosis: a Randomized double-blind study

被引：0
|
作者：
Hagino, H. [1 ]
Nishizawa, Y. [2 ]
Sone, T. [3 ]
Morii, H. [2 ]
Taketani, Y. [4 ]
Nakamura, T. [5 ]
Itabashi, A.
Mizunuma, H. [6 ]
Ohashi, Y. [4 ]
Shiraki, M. [7 ]
Minamide, T. [8 ]
Matsumoto, T. [9 ]
机构：
[1] Tottori Univ, Yonago, Tottori, Japan
[2] Osaka City Univ, Osaka, Japan
[3] Kawasaki Med Sch, Okayama, Japan
[4] Univ Tokyo, Tokyo, Japan
[5] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
[6] Hirosaki Univ, Hirosaki, Aomori, Japan
[7] Res Inst & Practice Involut Dis, Nagano, Japan
[8] ONO Pharamaceut Co Ltd, Osaka, Japan
[9] Univ Tokushima, Grad Sch Hlth Biosci, Tokushima, Japan
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
T395
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [1] Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study
    Shinji Uchida
    Tadaaki Taniguchi
    Takafumi Shimizu
    Taro Kakikawa
    Kotoba Okuyama
    Masahiko Okaniwa
    Hironori Arizono
    Koichi Nagata
    Arthur C. Santora
    Masataka Shiraki
    Masao Fukunaga
    Tatsushi Tomomitsu
    Yasuo Ohashi
    Toshitaka Nakamura
    Journal of Bone and Mineral Metabolism, 2005, 23 : 382 - 388
  • [2] Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study
    Uchida, S
    Taniguchi, T
    Shimizu, T
    Kakikawa, T
    Okuyama, K
    Okaniwa, M
    Arizono, H
    Nagata, K
    Santora, AC
    Shiraki, M
    Fukunaga, M
    Tomomitsu, T
    Ohashi, Y
    Nakamura, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (05) : 382 - 388
  • [3] Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study
    Matsumoto, T.
    Hagino, H.
    Shiraki, M.
    Fukunaga, M.
    Nakano, T.
    Takaoka, K.
    Morii, H.
    Ohashi, Y.
    Nakamura, T.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (08) : 1429 - 1437
  • [4] Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: A randomized placebo-controlled double-blind study
    Matsumoto, T.
    Hagino, H.
    Shiraki, M.
    Fukunaga, M.
    Nakano, T.
    Takaoka, K.
    Morii, H.
    Ohashi, Y.
    Nakamura, T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S17 - S17
  • [5] Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study
    T. Matsumoto
    H. Hagino
    M. Shiraki
    M. Fukunaga
    T. Nakano
    K. Takaoka
    H. Morii
    Y. Ohashi
    T. Nakamura
    Osteoporosis International, 2009, 20 : 1429 - 1437
  • [6] Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study
    Rosen, CJ
    Hochberg, MC
    Bonnick, SL
    McClung, M
    Miller, P
    Broy, S
    Kagan, R
    Chen, E
    Petruschke, RA
    Thompson, DE
    de Papp, AE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 141 - 151
  • [7] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S44
  • [8] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Melton, M
    Lewiecki, EM
    Rosen, R
    Bockman, RS
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S36 - S36
  • [9] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis.
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Yates, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S64 - S64
  • [10] Alendronate 70 mg Once Weekly and alendronate 10 mg Once Daily preference study in postmenopausal women with osteoporosis.
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, M
    Wang, L
    Yates, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S404 - S404
12345